Bank of New York Mellon’s Precision BioSciences DTIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-846
| Closed | -$9.26K | – | 4194 |
|
|
2023
Q4 | $9.26K | Hold |
846
| – | – | ﹤0.01% | 4264 |
|
|
2023
Q3 | $8.66K | Hold |
846
| – | – | ﹤0.01% | 4297 |
|
|
2023
Q2 | $13.4K | Sell |
846
-187
| -18% | -$2.95K | ﹤0.01% | 4315 |
|
|
2023
Q1 | $23.4K | Hold |
1,033
| – | – | ﹤0.01% | 4288 |
|
|
2022
Q4 | $36.9K | Sell |
1,033
-2
| -0.2% | -$71 | ﹤0.01% | 4278 |
|
|
2022
Q3 | $40K | Hold |
1,035
| – | – | ﹤0.01% | 4352 |
|
|
2022
Q2 | $50K | Sell |
1,035
-5,067
| -83% | -$245K | ﹤0.01% | 4339 |
|
|
2022
Q1 | $564K | Buy |
6,102
+166
| +3% | +$15.3K | ﹤0.01% | 3637 |
|
|
2021
Q4 | $1.32M | Buy |
5,936
+173
| +3% | +$38.4K | ﹤0.01% | 3231 |
|
|
2021
Q3 | $2M | Buy |
5,763
+788
| +16% | +$273K | ﹤0.01% | 2972 |
|
|
2021
Q2 | $1.87M | Sell |
4,975
-824
| -14% | -$310K | ﹤0.01% | 3022 |
|
|
2021
Q1 | $1.8M | Sell |
5,799
-363
| -6% | -$113K | ﹤0.01% | 2976 |
|
|
2020
Q4 | $1.54M | Buy |
6,162
+394
| +7% | +$98.5K | ﹤0.01% | 2989 |
|
|
2020
Q3 | $1.07M | Buy |
5,768
+303
| +6% | +$56K | ﹤0.01% | 3094 |
|
|
2020
Q2 | $1.37M | Buy |
5,465
+2,143
| +65% | +$535K | ﹤0.01% | 2924 |
|
|
2020
Q1 | $601K | Buy |
3,322
+266
| +9% | +$48.1K | ﹤0.01% | 3256 |
|
|
2019
Q4 | $1.27M | Buy |
3,056
+1,940
| +174% | +$808K | ﹤0.01% | 3103 |
|
|
2019
Q3 | $281K | Buy |
1,116
+457
| +69% | +$115K | ﹤0.01% | 3796 |
|
|
2019
Q2 | $262K | Buy |
+659
| New | +$262K | ﹤0.01% | 3841 |
|